Research Study of ATG and Rituximab in Renal Transplantation (RESTARRT)

Sponsors and Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Immune Tolerance Network (ITN)

Principal Investigator
James Markmann, MD, PhD, Massachusetts General Hospital


Continue Reading

ClinicalTrials.gov Identifier
NCT01318915